The Stochastic Oscillator for IBRN moved into overbought territory on October 22, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for IBRN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IBRN's RSI Oscillator exited the oversold zone, 14 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on IBRN as a result. In 62 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for IBRN just turned positive on October 20, 2026. Looking at past instances where IBRN's MACD turned positive, the stock continued to rise in 28 of 41 cases over the following month. The odds of a continued upward trend are 68%.
Following a +6.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBRN advanced for three days, in 175 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
IBRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
XERS saw its Momentum Indicator move above the 0 level on September 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 74 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 89%.
The Moving Average Convergence Divergence (MACD) for XERS just turned positive on September 21, 2026. Looking at past instances where XERS's MACD turned positive, the stock continued to rise in 36 of 42 cases over the following month. The odds of a continued upward trend are 86%.
XERS moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for XERS crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +7.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where XERS advanced for three days, in 220 of 256 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Aroon Indicator entered an Uptrend today. In 191 of 232 cases where XERS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
The 10-day RSI Indicator for XERS moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 38 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XERS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
XERS broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XERS's P/B Ratio (-203.411) is very low in comparison to the industry average of (10.407). P/E Ratio (-108.600) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (4.196) is also within normal values, averaging (178.797).
The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. XERS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
XERS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 44 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 23 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 36 | |
P/E GROWTH RATING 1..100 | 99 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| IBRN | XERS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 74% | 2 days ago 86% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 83% |
| Momentum ODDS (%) | 2 days ago 84% | 3 days ago 89% |
| MACD ODDS (%) | 2 days ago 68% | 3 days ago 86% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 79% | 2 days ago 86% |
| Advances ODDS (%) | 4 days ago 79% | 4 days ago 86% |
| Declines ODDS (%) | 10 days ago 81% | 10 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 71% |
| Aroon ODDS (%) | 2 days ago 82% | 2 days ago 82% |
A.I.dvisor indicates that over the last year, IBRN has been loosely correlated with JAZZ. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRN jumps, then JAZZ could also see price increases.
| Ticker / NAME | Correlation To IBRN | 1D Price Change % | ||
|---|---|---|---|---|
| IBRN | 100% | +0.75% | ||
| JAZZ - IBRN | 42% Loosely correlated | +1.26% | ||
| XERS - IBRN | 41% Loosely correlated | +0.70% | ||
| HRMY - IBRN | 37% Loosely correlated | -5.95% | ||
| STIM - IBRN | 21% Poorly correlated | +3.48% | ||
| LBRX - IBRN | 12% Poorly correlated | +0.48% | ||
More | ||||
A.I.dvisor indicates that over the last year, XERS has been loosely correlated with MIRM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then MIRM could also see price increases.
| Ticker / NAME | Correlation To XERS | 1D Price Change % | ||
|---|---|---|---|---|
| XERS | 100% | +0.70% | ||
| MIRM - XERS | 45% Loosely correlated | -0.41% | ||
| KROS - XERS | 38% Loosely correlated | +1.52% | ||
| AXON - XERS | 37% Loosely correlated | +2.98% | ||
| REPL - XERS | 36% Loosely correlated | +2.30% | ||
| BNTC - XERS | 36% Loosely correlated | +3.76% | ||
More | ||||